 Connection
Christina Chambers to Risk Assessment
This is a "connection" page, showing publications Christina Chambers has written about Risk Assessment.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.454 |
|
|
|
-
Bandoli G, Palmsten K, Chambers C. Acetaminophen use in pregnancy: Examining prevalence, timing, and indication of use in a prospective birth cohort. Paediatr Perinat Epidemiol. 2020 05; 34(3):237-246.
Score: 0.077
-
Smith CJF, Jones KL, Johnson DL, Bandoli G, Robinson LK, Kavanaugh A, Chambers CD. Risk of infantile hemangiomas in the offspring of women with autoimmune disease and the pathogenic implications of these lesions. Am J Med Genet A. 2018 03; 176(3):570-577.
Score: 0.068
-
De Ocampo MPG, Araneta MRG, Macera CA, Alcaraz JE, Moore TR, Chambers CD. Risk of gestational hypertension and preeclampsia in women who discontinued or continued antidepressant medication use during pregnancy. Arch Womens Ment Health. 2016 12; 19(6):1051-1061.
Score: 0.062
-
Bérard A, Wisner KL, Hultzsch S, Chambers C. Field studies versus database studies on the risks and benefits of medication use during pregnancy: Distinct pieces of the same puzzle. Reprod Toxicol. 2016 04; 60:123-8.
Score: 0.060
-
Baril L, Rosillon D, Willame C, Angelo MG, Zima J, van den Bosch JH, Van Staa T, Boggon R, Bunge EM, Hernandez-Diaz S, Chambers CD. Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Vaccine. 2015 Nov 27; 33(48):6884-91.
Score: 0.057
-
Chambers C. Safety of asthma and allergy medications in pregnancy. Immunol Allergy Clin North Am. 2006 Feb; 26(1):13-28.
Score: 0.030
-
Ewig CLY, Wang Y, Smolinski NE, Toyserkani GA, LaCivita C, Lackey L, Eggers S, Sahin L, Abu-Rustum RS, Bateman BT, Berard A, Chambers CD, Choby B, Conover EA, Greene MF, Hernández-Díaz S, Jamieson DJ, Obican SG, Polifka JE, Roussos-Ross K, Sheffield JS, Lavigne SV, Zimmermann EM, Laffan SB, DeLise AM, Gilsenan AW, Hammad TA, Hampp C, Hardy JR, Knox CA, Shields K, Smith MY, Sobel RE, Tassinari MS, Maro JC, Rasmussen SA, Winterstein AG. Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation Strategies. Drug Saf. 2025 Dec; 48(12):1387-1397.
Score: 0.029
-
Bandoli G, Chambers CD, Wells A, Palmsten K. Prenatal Antidepressant Use and Risk of Adverse Neonatal Outcomes. Pediatrics. 2020 07; 146(1).
Score: 0.020
-
Peyvandi S, Baer RJ, Chambers CD, Norton ME, Rajagopal S, Ryckman KK, Moon-Grady A, Jelliffe-Pawlowski LL, Steurer MA. Environmental and Socioeconomic Factors Influence the Live-Born Incidence of Congenital Heart Disease: A Population-Based Study in California. J Am Heart Assoc. 2020 04 21; 9(8):e015255.
Score: 0.020
-
Wang J, Johnson T, Sahin L, Tassinari MS, Anderson PO, Baker TE, Bucci-Rechtweg C, Burckart GJ, Chambers CD, Hale TW, Johnson-Lyles D, Nelson RM, Nguyen C, Pica-Branco D, Ren Z, Sachs H, Sauberan J, Zajicek A, Ito S, Yao LP. Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary. Clin Pharmacol Ther. 2017 Jun; 101(6):736-744.
Score: 0.016
-
Baer RJ, Chambers CD, Ryckman KK, Oltman SP, Norton ME, Jelliffe-Pawlowski LL. Risk of preterm birth among women using drugs during pregnancy with elevated a-fetoprotein. J Perinatol. 2017 03; 37(3):220-225.
Score: 0.016
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|